盘状蛋白结构域受体 (DDR) 是跨膜受体酪氨酸激酶 (RTK) 超家族的成员,与其他受体的区别在于,盘状蛋白结构域中存在盘状蛋白基序,并且利用胶原蛋白作为内部配体。已鉴定出两种类型的 DDR,即 DDR1 和 DDR2,具有不同的表达谱和配体特异性。
与胶原蛋白结合后,DDR 会传导涉及各种细胞功能的细胞信号,包括细胞粘附、增殖、分化、迁移和基质稳态。由突变或过表达导致的 DDR 功能改变与多种疾病有关,包括动脉粥样硬化、炎症、癌症和组织纤维化。DDR 已被视为药物发现的新型潜在分子靶点,并且人们正在加大力度,以识别针对该受体的新型小分子抑制剂。
Discoidin domain receptors (DDRs) are members of the transmembrane receptor tyrosine kinase (RTK) superfamily which are distinguished from others by the presence of a discoidin motif in the extracellular domain and their utilization of collagens as internal ligands. Two types of DDRs, DDR1 and DDR2, have been identified with distinct expression profiles and ligand specificities.
Upon collagen binding, DDRs transduce cellular signaling involved in various cell functions, including cell adhesion, proliferation, differentiation, migration, and matrix homeostasis. Altered DDR function resulting from either mutations or overexpression has been implicated in several types of disease, including atherosclerosis, inflammation, cancer, and tissue fibrosis. DDRs have been considered as novel potential molecular targets for drug discovery and increasing efforts are being devoted to the identification of new small molecule inhibitors targeting the receptors.
Recombinant Humanized Type III Collagen 28.6kDa 是一种 28.6kDa 的重组人源化 III 型胶原蛋白,具有促进皮肤细胞外基质再生、改善细胞微环境等多种生物学功能,也能抑制乳腺癌细胞的增殖、迁移和侵袭,并通过与整合素 (Integrin) 相互作用在细胞粘附、迁移、增殖和分化中发挥作用。
重组人源化 III 型胶原蛋白(Recombinant humanized type III collagen,MW 55900)分子量为 55900 Da,具有促进皮肤细胞外基质再生和改善细胞微环境等多种生物学功能,可抑制乳腺癌细胞的增殖、迁移和侵袭,并通过与整合素相互作用在细胞粘附、迁移、增殖和分化中发挥作用。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号